68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors

Clinical trial NCT04888481 · RECRUITING

Trial details

NCT number: NCT04888481
Sponsor: University of Alberta
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumors

Start date: 2022-02-15
Primary completion: 2027-08-31
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.